Overview
William Hane is Co-Founder & CEO at Pharmacometrics AI[1][3]. Hane's team develops advanced AI-powered automation tools and machine learning solutions in pharmacometrics[2]. The company offers DrLevy.AI, an end-to-end platform for pharmacometric analysis from planning through regulatory submission[2], and pharmacometrics.ai, which provides open-source tools and resources[2]. Prior to founding Pharmacometrics AI in May 2024[3], Hane was Co-Founder of 66Pharm.com from May 2022 to September 2023[4] and Founder and Developer of Projectila from August 2021 to April 2022[5]. Hane holds a Bachelor's degree in Computer Science and Data Science from Boston University[6] and a Master's degree in Biostatistics from Stanford University[7].
Profile introduction
My team is at the forefront of developing advanced AI-powered automation tools and machine learning solutions in pharmacometrics. We've spent the past two years right at the intersection of AI and pharmacometrics, building the tools that help teams fail faster, cheaper, and with data instead of guesswork. Here's current what we have at pharmacometric.com : → DrLevy.AI: An end-to-end platform that takes pharmacometric analysis from planning through regulatory submission. One unified environment. No more duct-taping five tools together. → pharmacometrics.ai: Open-source tools and resources…
Career history
- Co-Founder & CEOMay 2024 to presentPharmacometrics AI
- Co-FounderMay 2022 to Sep 202366Pharm.com
- Founder and DeveloperAug 2021 to Apr 2022Projectila
Education
Bachelor's degree, Computer Science, Data ScienceBoston University
Master's degree, BiostatisticsStanford University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.